Discovery of ErbB/HDAC inhibitors by combining the core pharmacophores of HDAC inhibitor vorinostat and kinase inhibitors vandetanib, BMS-690514, neratinib, and TAK-285
synthesized and characterized、mass spectrometry、kinase inhibitors、high resolution、cancer therapy、cell lines
28
R9 ;R73
funding from the National Natural Science Foundation of China21272134;Shenzhen Municipal GovernmentCXB201104210014A and 20150113A0410006
2017-08-14(万方平台首次上网日期,不代表论文的发表时间)
共8页
1220-1227